Surprises in the Physiopathology of Critical Ischemia

Luminal thrombotic occlusions associated with non-significant atherosclerosis are commonly observed in patients with critical lower limb ischemia, which suggests the possibility of thromboembolic disease as a great contributor to ischemia. This was particularly verifiable in infrapopliteal vessels, thus showing a possible mechanism of progression from peripheral vascular disease to critical ischemia, as well as a possible role for antithrombotic agents.

¿Es durable el TAVI a más de 5 años?Arteries from 95 patients (121 amputations) were studied; 75 of these patients had suffered amputations due to critical ischemia, while the remaining had amputations for other reasons. The pathological characteristics were recorded separately for the femoral artery, the popliteal artery, and infrapopliteal arteries.

 

In the 239 arteries from patients with critical ischemia, atherosclerotic plaques were more frequently found in the femoropopliteal area compared with the infrapopliteal area (67.6% vs. 38.5%; odds ratio [OR]: 5.47; p = 0.003). Among these 239 arteries, 69% presented ≥70% stenosis as a consequence of pathological intimal thickening, fibroatheroma, fibrocalcific lesions, or restenosis. Others were associated with luminal thrombi (23.6%) or thrombi without significant atherosclerotic lesions.


Read also: Differences in Stroke between TAVR and SAVR in Intermediate Risk Patients.


The presence of chronic luminal thrombi was more frequent in arteries with non-significant atherosclerosis (OR: 16.7; p = 0.002), which was more common in infrapopliteal arteries than in femoropopliteal arteries (p = 0.0041). However, acute thrombotic occlusion was less frequent in arteries with larger diameter.

 

Conclusion

Thrombotic luminal occlusion is frequently associated with non-significant atherosclerosis and it is usually observed in patients with critical ischemia who required amputation. Thrombosis may be a mechanism of progression from intermittent claudication to critical ischemia, and a possible role for antithrombotic agents is suggested.

 

Original title: Pathology of Peripheral Artery Disease in Critical Limb Ischemia.

Reference: Navneet Narula et al. J Am Coll Cardiol 2018. Online before print.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

ACC-2025 Congress Second Day Key Studies

BHF PROTECT-TAVI (Kharbanda RK, Kennedy J, Dodd M, et al.)The largest randomized  trial carried out across 33 UK centers between 2020 and 2024, assessing...

Prospective Analysis of the Feasibility of the PASCAL System for Transcatheter Mitral Repair: OneForAll Registry

Courtesy of Dr. Juan Manuel Pérez. Mitral transcatheter edge-to-edge repair (M-TEER) is an effective option for patients with severe mitral regurgitation who are at high...

Left Bundle Branch Block after TAVR: What Is Its Impact?

Courtesy of Dr. Juan Manuel Pérez. Left bundle branch block (LBBB) is a common complication following transcatheter aortic valve replacement (TAVR), which can be either...

Multicenter Experience with 3D Intracardiac Echocardiography for Guiding Interventional Cardiac Procedures

Courtesy of Dr. Juan Manuel Pérez. Imaging techniques play a fundamental role in interventional cardiac procedures. Intracardiac echocardiography (ICE) appears as an alternative to transesophageal...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACC-2025 Congress Second Day Key Studies

BHF PROTECT-TAVI (Kharbanda RK, Kennedy J, Dodd M, et al.)The largest randomized  trial carried out across 33 UK centers between 2020 and 2024, assessing...

ACC 2025 | FAME 3: FFR Guided PCI vs CABG 5 Year Outcomes.

Earlier studies comparing percutaneous coronary intervention (PCI) vs coronary artery bypass graft (CABG) have shown fewer events at long term for the surgical strategy.  However,...

ACC 2025 | API-CAT: Reduced vs. Full Dose Extended Anticoagulation in Patients with Cancer Related VTE

The risk of cancer related recurrent venous thromboembolism (VTE) will drop over time, while bleeding risk will persist. At present, it is recommended we...